EU Medicines Agency Says No Conclusion on Link Between AstraZeneca Vaccine, Blood Clots
April 06 2021 - 9:17AM
Dow Jones News
By Cecilia Butini
The E.U. Medicines Agency hasn't yet reached a conclusion on a
link between AstraZeneca PLC's Covid-19 shot and a rare blood
clotting condition, an agency spokeswoman told the Wall Street
Journal on Tuesday, adding that a review from the agency's
Pharmacovigilance Risk Assessment Committee is still underway.
The European regulator responded to a comment request after
Marco Cavaleri, who is the head of EMA's vaccines strategy, told
Italian daily Il Messaggero that a link between AstraZeneca's shot
and the disease was clear, although the agency hadn't yet finished
its review.
The EMA spokeswoman said the agency would hold a press briefing
on the matter as soon as its review gets finalized, which is
expected to happen on Wednesday or Thursday.
AstraZeneca told The Wall Street Journal that it would decline
to comment on Mr. Cavaleri's position.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
April 06, 2021 10:02 ET (14:02 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
From Apr 2024 to May 2024
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
From May 2023 to May 2024